Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kineta
AddedFeb 19, 2024
UpdatedJun 18, 2026
Kineta

Kineta

Acquired

Seattle-based Kineta, Inc. develops novel immuno-therapies for autoimmune diseases, antivirals, and chronic pain.

HQ
Seattle, WA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Founded in Seattle, Washington, Kineta, Inc. is a biotechnology company dedicated to developing next-generation immunotherapies. The company's core mission is to address the mechanisms of cancer immune resistance and provide novel treatments for autoimmune diseases, antivirals, and chronic pain. Kineta's product pipeline includes innovative therapies such as KVA, a VISTA blocking cancer therapy, aimed at improving patient outcomes in the United States and potentially worldwide.

Kineta has attracted notable investors and affiliations within the biotech industry, contributing to its credibility and growth. The company has achieved significant milestones in advancing its immunotherapy candidates through various stages of clinical development. Kineta's impact is marked by its commitment to pioneering treatments that tackle complex medical challenges, positioning it as a key player in the field of immunotherapy and biopharmaceutical innovation.

Kineta - Similar Companies

Nantkwest logo

Nantkwest

Immunome logo

Immunome

Synthekine logo

Synthekine

synthekine.com

Cleveland BioLabs logo

Cleveland BioLabs

INmune Bio logo

INmune Bio

inmunebio.com

Therabiol logo

Therabiol

Inimmune logo

Inimmune

inimmune.com

Northwest Biotherapeutics logo

Northwest Biotherapeutics

nwbio.com

KeifeRx logo

KeifeRx

keiferx.com

Cel-Sci logo

Cel-Sci

cel-sci.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

Kyverna Therapeutics logo

Kyverna Therapeutics

Kezar Life Sciences logo

Kezar Life Sciences

ManaT Bio logo

ManaT Bio

clasptx.com

Imvaq Therapeutics logo

Imvaq Therapeutics

Kineta - Quick Facts

Who are Kineta's competitors?

Companies similar to Kineta include Nantkwest, Immunome, Synthekine and Cleveland BioLabs.

When was Kineta founded?

Kineta was founded in 2008.

Where is Kineta's headquarters located?

Kineta's headquarters is located in Seattle, WA, US.

When was Kineta's last funding round?

Kineta's most recent funding round was for $3M (USD) in October 2023.

How much has Kineta raised to-date?

As of Oct 4, 2023, Kineta has raised a total of $98M (USD).

Kineta - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Immunotherapies
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 541618Other Management Consulting Services
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 541600Management, Scientific, and Technical Consulting Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541610Management Consulting Services
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8748Business Consulting Services, Not Elsewhere Classified
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8740Management And Public Relations Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7490Other professional, scientific and technical activities n.e.c.